Stuart Flechner, M.D.

Stuart M. Flechner, MD, is Director of Clinical Research in the Section of Renal Transplantation at Cleveland Clinic, and a Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio.

Dr. Flechner received a BA in zoology and his MD from the University of California at Los Angeles. After completing a residency in surgery and urology at Moffitt Hospital of the University of California, San Francisco, he did a fellowship in transplantation and renal vascular surgery at Cleveland Clinic.

Dr. Flechner has held academic appointments in the Division of Organ Transplantation at the University of Texas Medical School, Houston, and in the Division of Transplantation at Stanford University School of Medicine. His academic interests include the medical and surgical management of renal transplant recipients, transplant biology and the development and application of new and innovative immunosuppressive agents. He has recently completed a sabbatical at Scripps Research Institute in California in the Department of Molecular and Experimental Medicine. 

Dr. Flechner has authored more than 225 scientific articles, chapters and reviews, and is a member of the Editorial Board of Transplantation. He is also an ad hoc reviewer for 18 scientific journals in the fields of transplantation, surgery and urology. Current projects include the development of calcineurin-free immunosuppressive regimens and signature patterns of gene expression in transplanted kidneys in various stages of function.

• Visiting Scientist, Department of Molecular and Experimental Medicine, Scripps Research Instititue, La Jolla, Calif.

Renal transplantation, vascular disease, oncology.

• Best Doctors, Cleveland magazine
• Top Doctors in America
• Fellow, American College of Surgeons

• American Urological Association
• American Society of Transplant Surgeons
• The Transplantation Society
• American Society of Transplantation
• Society of University Surgeons

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Flechner has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)